Tata 1mg Labs, a leader in diagnostic excellence, is proud to announce that it has achieved an outstanding score of 99.48% in the College of American Pathologists (CAP) Proficiency Testing for January to June 2024.

CAP Proficiency Testing is a globally recognized benchmark for excellence in laboratory practices. This rigorous testing ensures that labs maintain the highest standards of diagnostic accuracy and reliability. Achieving high scores on this test indicates that Tata 1mg Labs’ processes meet and exceed these stringent standards, reinforcing our commitment to providing top-tier diagnostic services.

Our journey of continuous improvement has been remarkable. In 2022, we scored 95.7% in the CAP Proficiency Testing, followed by 97.3% in 2023. Our latest score of 99.48% in 2024 surpasses the global average, showcasing our dedication to enhancing diagnostic accuracy and patient care.

Chief Pathologist at Tata 1mg Labs, remarked, "We are immensely proud of this achievement. It reflects our relentless pursuit of excellence and commitment to providing the highest quality diagnostic services. External validations like CAP Proficiency Testing are crucial in ensuring our lab processes are of the highest quality, minimizing the risks of incorrect test results and enhancing patient safety."